- Scrip Originals
- Featured Topics
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AdaptVac
The FDA granted an expected, though long-awaited, approval to the COVID-19 vaccine. Also, Korean regulators have begun a review of Russian vaccine CoviVac, while Bavarian Nordic has initiated a Phase II study of its vaccine booster candidate and received a commitment for up to DKK 800m from the Danish government.